Search - tctmd.com

Displaying 61 - 80 of 743

Sort: Relevancy | Date

Presentation TCT 2017

TAVR: Current Devices and Indications

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Vinod H. Thourani

November 01, 2017

Presentation TCT 2017

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

Presenter: Adrian P. Banning, Ted Feldman, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Presenter: Adrian P. Banning, Ted Feldman, Eberhard Grube

November 01, 2017

Presentation TCT 2017

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Presenter: Alfredo Trento, David J. Cohen

November 01, 2017

Presentation TCT 2017

Case Conclusion: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis How I Treated

Presenter: James B. Hermiller Jr., John D. Puskas, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Presenter: Adrian P. Banning, Ted Feldman, Bernard Prendergast

November 01, 2017

Presentation TCT 2017

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jonathon A. Leipsic, Maurice E. Sarano, Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Presenter: Adrian P. Banning, Ted Feldman, Raj Makkar

November 01, 2017

Presentation TCT 2017

Case Introduction: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis

Presenter: James B. Hermiller Jr., John D. Puskas, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

First-in-Human Experience With Aortix Intra-aortic Pump

Presenter: Daniel Burkhoff, Samir R. Kapadia, Amit N Vora

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Presenter: Bernard Prendergast, Brian K. Whisenant, Victoria Delgado

November 01, 2017

Presentation TCT 2017

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz

November 01, 2017

Presentation TCT 2017

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Presenter: Bernard Prendergast, Brian K. Whisenant, David J. Cohen

November 01, 2017

Presentation TCT 2017

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Presenter: Bernard Prendergast, Brian K. Whisenant, Eric Van Belle

November 01, 2017

Presentation TCT 2017

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Presenter: Bernard Prendergast, Brian K. Whisenant

November 01, 2017

Advertisement

TAVR: Current Devices and Indications

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

When to Use Cerebral Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Case Conclusion: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis How I Treated

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Post-TAVR Valve Thickening: Current Data and Open Questions

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Case Introduction: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis

First-in-Human Experience With Aortix Intra-aortic Pump

Live From Denver: TCT 2017, Day Three

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content